U.S. Pharma Stock News

Nabors Industries (NBR) has drawn fresh attention after recent trading, with the share price near $76.60 and performance over the past month and past 3 months contrasting with weaker multi year total returns. See our latest analysis for Nabors Industries. The current share price of US$76.60 comes after a 30 day share price return of 14.6% and a 90 day share price return of 39.45%. The 1 year total shareholder return of 99.38% contrasts with weaker 3 and 5 year total shareholder returns,...

Ford Motor (NYSE:F) has announced wide scale safety recalls affecting more than 4,000,000 trucks and SUVs in the United States. The recalls address software issues tied to braking and lighting systems, as well as hardware faults that may impact steering control. These actions introduce fresh questions around Ford's quality controls and potential financial and reputational impacts. For shareholders, these recalls come with Ford Motor trading at $12.7, after a 10.6% decline over the past week...

First Solar recently reported its fourth-quarter and full-year 2025 results, showing higher sales and net income year on year, and issued 2026 guidance calling for US$4.9 billion to US$5.2 billion in net sales alongside planned module shipments of 17.0 GW to 18.2 GW. At the same time, the company secured a new US$1.50 billion unsecured revolving credit facility, enhancing financial flexibility as it pursues its manufacturing and growth plans. We’ll now examine how this strong 2025 earnings...

Coupang, Inc. has already reported fourth-quarter 2025 results, with revenue rising to US$8.84 billion but swinging from a prior-year profit to a US$26 million net loss, while full-year 2025 revenue increased to US$34.53 billion and net income to US$208 million. Alongside these results, Coupang completed a US$243.50 million share repurchase program and filed a US$1.88 billion shelf registration for employee stock offerings, highlighting an active mix of capital returns and equity...

In the past quarter, Cardinal Health reported revenue and earnings that exceeded analyst expectations, reflecting strong demand across its pharmaceutical and medical distribution operations and improved efficiency. An interesting angle for investors is how favorable valuation metrics and upgraded analyst assessments have highlighted Cardinal Health as a potential value-focused healthcare distributor with improving fundamentals. With these better-than-expected quarterly results highlighting...

In recent weeks, Ameriprise Financial has faced insider share sales by several top executives, the planned retirement of a key Advice & Wealth Management leader, and an SEC fine related to compliance failures involving unapproved electronic messaging platforms. At the same time, its Columbia Threadneedle asset management arm was ranked by Barron's among the top fund families across 1-, 5-, and 10-year periods, underscoring the group’s long-term investment performance. We’ll examine how the...

Cipher Digital (CIFR) is in the middle of a major business reset, moving from bitcoin mining to high performance computing data centers backed by long-term capacity leases and newly raised bond financing. See our latest analysis for Cipher Digital. Despite the pivot to high performance computing data centers and new long term leases, recent trading has been choppy, with a 1 day share price return of 6.66% decline and a 90 day share price return of 21.04% decline. This contrasts with a very...

Event context and recent share performance Arthur J. Gallagher (AJG) has been drawing attention after a period of mixed share performance, with the stock showing gains over the past week but declines over the past month, past 3 months, year to date, and past year. In this context, some investors are reassessing how the company’s current share price of $225.23 and its recent return profile align with its scale, with reported revenue of $13.0b and net income of $1.5b. See our latest analysis...

Pinnacle West Capital (PNW) has drawn fresh attention after recent share price moves, with the stock last closing at $102. Investors are weighing this level against the company’s fundamentals and recent return profile. See our latest analysis for Pinnacle West Capital. The recent move to a $102 share price sits within a stronger trend, with a 30 day share price return of 9.02% and a year to date share price return of 15.72%, alongside a 5 year total shareholder return of 63.94%. Together,...

Autoliv (NYSE:ALV) has announced that board members Mr. Franz-Josef Kortüm and Mr. Martin Lundstedt will not stand for re election at the next Annual Meeting. The upcoming departures will lead to changes in the company’s board composition and governance structure. For you as an Autoliv shareholder, these board changes come at a time when the stock trades around $113.07, with a value score of 6. The shares show mixed recent performance, with a 7% decline year to date and a 26.8% return over...

What is moving Applied Optoelectronics right now? Applied Optoelectronics (AAOI) has been drawing attention after a sharp share price move, with the stock returning 119% over the past month and 272% over the past 3 months. For investors, these rapid swings put a spotlight on how the business fundamentals, including recent revenue and net income trends, line up with the current US$95.34 share price. See our latest analysis for Applied Optoelectronics. That recent surge sits on top of a much...

New CEO’s transformation plan puts Ichor Holdings (ICHR) in focus A leadership shift at Ichor Holdings (NasdaqGS:ICHR), with a new CEO prioritizing operational discipline, margin expansion, and core semiconductor activities, has pushed the stock into the spotlight for investors reassessing the story. See our latest analysis for Ichor Holdings. The recent leadership change comes after a powerful run in Ichor Holdings’ share price, with a 90 day share price return of 159.2% and year to date...

Recent share performance and business snapshot Bank of N.T. Butterfield & Son (NTB) has seen mixed recent share performance, with a 1 day return of a 0.88% decline, a 7 day move of a 0.35% decline and a 1 month performance of a 1.89% decline. Over the past 3 months, the stock shows a 5.26% gain, with a year to date return of 2.25% and a 1 year total return of 39.34%. Longer term, 3 year and 5 year total returns stand at 67.26% and 73.29% respectively. The bank reports revenue of US$606.792...

Core Scientific (CORZ) just posted its FY 2025 Q4 numbers, reporting revenue of US$79.8 million, basic EPS of US$0.68 and net income of US$216.0 million. The company has seen quarterly revenue move in a tight band between US$78.6 million and US$95.4 million since late 2024, while basic EPS has swung from a loss of US$1.17 per share in 2024 Q3 to a profit of US$0.68 in 2025 Q4, highlighting how volatile margins have been for shareholders tracking the story. With trailing twelve month EPS still...

Enovis Corporation recently reported its fourth-quarter and full-year 2025 results, including sales of US$575.76 million for the quarter and US$2.25 billion for the year, alongside a goodwill impairment charge of US$501.31 million that kept the company in a loss-making position. At the same time, Enovis issued 2026 guidance calling for US$2.31 billion to US$2.37 billion in revenue and 4–6% organic growth, highlighting how ongoing product innovation and margin efforts are being weighed...

If you are wondering whether Church & Dwight is offering fair value at its current share price, you are not alone. This article is built to help you assess what you are really paying for. The stock last closed at US$103.02, with a 7.0% return over the past 30 days, a 24.7% return year to date, but a 5.7% decline over the past year and longer term returns of 27.6% over 3 years and 35.9% over 5 years. Recent interest in Church & Dwight reflects its position as a long established household...

Everpure has changed its corporate name from Pure Storage Inc. to Everpure Inc. The change follows a certificate of amendment filed in Delaware. The company continues to trade under ticker NYSE:PSTG for now. For investors following NYSE:PSTG, the formal shift to Everpure Inc. signals that management wants the brand to reflect its current identity and priorities. The business remains centered on data storage and related solutions, an area that continues to attract attention as organizations...

IonQ acquired SkyWater Technology, a U.S. based quantum foundry, creating what it describes as a vertically integrated, full stack trapped ion quantum platform with domestic manufacturing. The company deployed the Romanian National Quantum Communication Infrastructure, one of the largest quantum secure networks in Europe. These moves expand IonQ's role across quantum computing, networking, and security, and may influence how investors assess its competitive position. IonQ (NYSE:IONQ) is...

Okta recently reported past-quarter results showing revenue and adjusted earnings growth, driven largely by enterprise uptake of its newer AI-focused security tools and identity offerings. The launch of Auth0 for AI Agents and an expanded AI security partnership with the PGA of America highlight Okta’s push into securing emerging AI-driven workloads and user experiences. With Okta leaning further into AI identity security via Auth0 for AI Agents, we’ll now examine how this reshapes its...

Wondering whether Stoke Therapeutics at around US$33.78 is starting to look expensive or if there is still value on the table? This article walks through the key numbers so you can judge for yourself. The stock has been volatile, with a 4.8% decline over the last 7 days, an 11.3% gain over 30 days, a 9.3% return year to date, a 345.6% return over 1 year, a 266.0% return over 3 years, and a 34.9% decline over 5 years. These price swings sit against a backdrop of ongoing attention on Stoke...

If you are looking at AGNC Investment and wondering whether the current share price gives you enough value for the risk you are taking, this article is built to walk you through that question step by step. The stock last closed at US$11.00, with returns of 2.7% decline over 7 days, 3.5% decline over 30 days, a 0.6% gain year to date, 24.4% over 1 year, 62.2% over 3 years, and 31.3% over 5 years. Recent price moves have been accompanied by ongoing attention on AGNC Investment's interest rate...

Fidelis Insurance Holdings Limited recently reported past fourth quarter 2025 results showing revenue of US$600.9 million and net income of US$117.8 million, alongside a full-year profit of US$225.5 million, while also maintaining its quarterly dividend at US$0.15 per share. At the same time, Fidelis completed and expanded sizeable share repurchase programs, including an agreement to buy all remaining shares held by founding shareholder CVC Falcon Holdings at US$19.00 per share, a price...

Novo Nordisk (NYSE:NVO) received FDA approval for three new pediatric indications for its long acting growth hormone, Sogroya. The approvals cover multiple growth disorders in children in the US, expanding Sogroya’s treatment reach. The company also entered a partnership with Vivtex to work on oral biologic treatments for obesity, diabetes, and related conditions. These updates come as Novo Nordisk shares trade at $36.66, with the stock showing a 10.2% return over the past five years but a...

Formula One Group (FWON.K) is back on investors’ radar after year-end results showed higher revenue and a return to profit, alongside a fresh five-year Concorde Agreement and expanded global media partnerships. See our latest analysis for Formula One Group. At a share price of US$88.81, Formula One Group has given investors a 1-year total shareholder return decline of 2.5%, although the 3-year and 5-year total shareholder returns of 28.2% and 100.5% suggest longer term holders have seen...